Bioscience Make-Over

Echoing the centuries-old debate among scientists over how to organize and name Earth's species, authors of National Research Council (NRC) reports rating research-doctorate programs have also struggled over the "taxonomy" of disciplines within the biosciences. Allan Cartter, in his 1966 report An Assessment of Quality In Graduate Education (Washington, D.C., American Council on Education), observed that grouping programs within the biological sciences represented a challenge, owing to the vari

Written byKaren Young Kreeger
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Almost 30 years later, the diversity is even greater, as a result of the "important changes in the underlying knowledge base [in the biological sciences] in the last decade," according to NRC's 1995 report, Research-Doctorate Programs in the United States: Continuity and Change (M.L. Goldberger, B.A. Maher, P.E. Flattau, eds., National Academy Press, Washington, D.C.).

"There's been enormous growth in the biosciences and enormous changes as new technologies and new fields have emerged," asserts Pamela Mellon, a professor of reproductive medicine and neurosciences at the University of California, San Diego, and an NRC report committee member. "The main point that I think is important to remember about the evolution of the biosciences is that it is in a sense driven by the great leap forward that the science has made in redefining itself. The old lockstep definitions no longer apply because we're all using new technology to approach questions that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies